BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of xenobiotics
,
Hepatitis
,
Hippocampus
,
Early pregnancy factor
,
GATA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ar protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast SKBR3 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MDAMB231 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Breast cancer HS578T cells treated with ligand perturbagens
L1000 CMAP - Breast carcinoma BT20 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Discovery of N-(4-(Benzyloxy)-phenyl)-sulfonamide Derivatives as Novel Antagonists of the Human Andr…
5α-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen recep…
A recurrent synonymous mutation in the human androgen receptor gene causing complete androgen insens…
Editorial Comment on Exploring androgen receptor signaling pathway in prostate cancer: A path to new…
Androgen receptor: Structure, signaling, function and potential drug discovery biomarker in differen…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-…
Effect of Human Plasma Protein Transfusion With and Without Crystalloids During Major Liver Resectio…
Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ